Here are the 10-K annual reports from Medwellai Inc (MWAI) in our archive since June 2025, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A 10-K covers the audited annual report, with the full financial statements, so if you follow MWAI and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full MWAI filings page.
MedWellAI, Inc. reported revenue of $527,857 for the year ended June 30, 2026, compared with $594,768 for the year ended June 30, 2025. Commissions were $437,857 and rental income was $90,000; online sales were zero. Net loss attributable to MedWellAI was $1,589,465, compared with $3,607,145, and operating activities used $307,030 in cash.
As of June 30, 2026, current liabilities exceeded current assets by $7,847,263; cash was $86,222 and the accumulated deficit was $90,263,345. The company and its auditor said recurring operating losses raise substantial doubt about its ability to continue as a going concern. Management reported that disclosure controls and internal controls over financial reporting were not effective.
MedWellAI discontinued digital-asset mining and now focuses on commissions through a platform connecting in-office buyers with FDA-registered 503B pharmacies. In April 2026, the FDA proposed excluding semaglutide, tirzepatide and liraglutide from the 503B Bulks List. If finalized, the proposal could materially limit the supply of products the company distributes.
MedWellAI, Inc. reports a difficult year with material impairments, debt defaults and a large accumulated deficit that raise substantial doubt about its ability to continue as a going concern. The company acquired 51% of Healthy Lifestyle and recorded a $670,329 goodwill impairment after deciding to abandon that business; earn-out targets tied to Healthy Lifestyle were not met so no post-closing payments are due. The company reported an accumulated deficit of $88,673,880 and disclosed operations that produced cash shortfalls. A note payable went into default and the lender reduced default interest to 10% effective April 1, 2024; interest expense of $50,694 and $81,389 was recorded in fiscal 2025 and 2024. Management also issued 50,000 Series B preferred shares to a related party, valued on an as-converted basis at $8,300,000, convertible at 100:1. The filing discloses discontinued mining operations and other one-time adjustments but lacks full, contiguous financial tables in this extract.